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The rapid development of nanotechnology and its application in all areas of life not only provides 
many chances, but also poses potential risks for users and their environment. Modern health-
based risk assessment strategies for nanomaterials include three major pillars: analytical data 
about surface chemistry, composition and size distribution patterns of manufactured 
nanomaterials (NMs), toxicological data from in vitro experiments and lastly also from in vivo 
experiments. This thesis provides scientific advancements for each of the three pillars, in order to 
enhance a holistic health based risk assessment approach for nanomaterials. 
 
The chemical characterization, quantification and the determination of size distributions is a key 
issue in defining a NM and predicting its interactions. In the context of the research work of this 
dissertation, a further development of the single particle inductively coupled plasma mass 
spectrometry (sp-ICP-MS) technique is presented. With the help of this method the fast and 
reliable size distribution characterization of metal containing NMs is now possible. The new 
approach is based on the application of a dual sample introduction system using both, a 
pneumatic nebulizer and a micro droplet generator. The design of the system allows a 
comprehensive size characterization of NMs within 20 minutes. The obtained data is evaluated 
using three approaches presented in the thesis. Each of these approaches is based on a unique 
calibration principle. Thus, this work contributes to an independent and precise analytical 
characterization of NMs.  
 
Furthermore, in order to gain insights into the solubility behavior of NMs after oral uptake a in 
vivo toxicological assessment was carried out. Aluminum-containing NMs (Al2O3 and Al0) were 
administered to rats via oral gavage for three-days and the aluminum organ burden was 
determined. The comparatively low exposure level in combination with the ubiquitous aluminum 
background posed a challenge for conventional analytical techniques. We solved this problem in 
the present study by means of a matrix calibration and the application of a daily response factor, 
which enabled us not only to reliably determine the applied materials in organic matrices, but 
also to obtain information on the uptake and distribution of the two NMs. A special focus was 
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laid on the differences in the uptake of the NMs and the subsequent distribution of the materials 
in the intestinal and systemic organs (liver, kidney, spleen). Our work has shown that the 
materials behave significantly different, irrespective of similar size and composition. Especially 
shape and surface properties of the NM could be identified as decisive factors for these 
differences. 
 
Moreover, in vitro experiments with the two aluminum containing NMs in human keratinocytes 
were carried out to further investigate the cellular uptake and intracellular distribution as well as 
the resulting metabolic changes within the cell. In order to make the exposure scenario more 
realistic and mimic ingredients of cosmetic products, the influence of the two bioactive vitamins 
A and D3 was tested in addition to the two NMs. The ICP-MS results showed significant 
differences between the uptake of the two NMs after addition of the vitamins. Time of Flight 
secondary ion mass spectrometry (ToF-SIMS) was then used to further investigate metabolic 
changes in the cell. It was found that the increased uptake of Al0 NMs after vitamin D3 addition 
was due to a loss of cell membrane integrity. The combination of Al2O3 NM and vitamin D3 led 
to an increase in membrane stability. However, the exact difference could not be conclusively 
clarified in the study. Our results indicate the need for further research to identify which 
properties of a NM are decisive for the observed different interactions. 
  
In summary, this work contributes to a more precise characterization and detection of NMs and to 
a better explanation of their interactions with biological systems. The pillar based methodology 
can be used for future research and thus contributes to a safer and more reliable application of 






Die rasante Entwicklung der Nanotechnologie und ihrer Anwendung in sämtlichen Bereichen des 
Lebens bietet nicht nur viele Chancen, sondern birgt auch Risiken für die Anwender und ihre 
Umwelt. Moderne Risikobewertungsstrategien für Nanomaterialien umfassen drei Hauptfelder: 
die physikochemische Charakterisierung von Nanomaterialien Durchführung von in vitro-
Experimenten und abschließend auch in vivo-Toxizitätstestung. Diese Arbeit zeigt 
wissenschaftliche Fortschritte für jedes dieser drei Themenfelder, um den ganzheitlichen 
Risikobewertungsansatz für Nanomaterialien zu verbessern.  
Ein zentraler Punkt bei der Definition eines NMs sowie für die Vorhersage von Interaktionen von 
Nanomaterialien mit lebenden Organismen stellt die analytische Charakterisierung der Größe dar. 
Im Rahmen der Forschungsarbeit dieser Dissertation wird eine Weiterentwicklung der single 
particle inductively coupled plasma mass spectrometry (sp-ICP-MS) Technik vorgestellt. Mit 
Hilfe dieser Methodik ist die schnelle und zuverlässige Größencharakterisierung von 
Nanomaterialien möglich. Der neue Ansatz basiert auf der Anwendung eines dualen 
Probeneintragssystems, welches sowohl einen pneumatischen Zerstäuber als auch einen micro 
droplet generator verwendet. Der Aufbau des Systems ermöglicht eine umfassende Erfassung der 
Partikelgrößenverteilung von Nanomaterialien innerhalb von nur 20 Minuten. Die erhaltenen 
Daten werden über drei in der Arbeit vorgestellte Ansätze ausgewertet. Jeder dieser Ansätze 
beruht auf einem einzigartigen Kalibrierungsprinzip. Somit trägt diese Arbeit zu einer 
unabhängigen und präzisen Charakterisierung von Nanomaterialien bei.  
Um zu einer verlässlichen Risikobewertung von Nanomaterialien beizutragen, wurden die orale 
Aufnahme und Biokinetik von aluminiumhaltige Nanomaterialien (Al2O3 und Al0) in einer 3 
Tages Studie an Ratten getestet. Die vergleichsweise geringe Expositionsmenge in Kombination 
mit dem ubiquitären Aluminiumhintergrund stellte eine Herausforderung für die konventionelle 
Analytik dar. Wir lösten dieses Problem in der vorliegenden Studie mittels einer 
Matrixkalibration und der Einführung eines Daily Response Factors, wodurch wir nicht nur in der 
Lage waren, die applizierten Materialien in organischen Matrices verlässlich zu bestimmen, 
sondern auch Aussagen über die Biokinetik der beiden Nanomaterialien zu treffen. Ein 
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besonderer Fokus wurde dabei auf die Unterschiede in der Aufnahme der Nanomaterialien und 
der anschließenden Verteilung der Materialien im Darm und den analysierten Organen gelegt. 
Unsere Arbeit hat gezeigt, dass trotz ähnlicher Größe und Komposition eine signifikant 
unterschiedliche Verteilung der Nanomaterialien im Darm und den untersuchten Organsystemen 
vorliegt. Insbesondere die Form sowie die Oberflächenbeschaffenheit der Materialien könnten 
entscheidende Faktoren für diese Unterschiede sein. 
Um die unterschiedliche Aufnahme und intrazelluläre Verteilung sowie daraus resultierende 
Veränderungen des zellulären Metabolismus zu erfassen, wurden humanen Keratinozyten mit den 
beiden aluminiumhaltigen Nanomaterialien exponiert. Um das Expositionsszenario etwas 
realistischer zu gestalten, wurden neben den Nanomaterialien der Einfluss von den beiden 
bioaktiven Vitaminen A und D3 getestet. Die ICP-MS Ergebnisse zeigten deutliche Unterschiede 
zwischen der Aufnahme der beiden Nanomaterialien nach Zugabe der Vitamine. 
Flugzeitsekundärionenmassenspektrometrie (ToF-SIMS) wurde anschließend eingesetzt, um 
metabolische Veränderungen in der Zelle näher zu untersuchen. Es zeigte sich dabei, dass die 
vermehrte Aufnahme von Al0 Nanomaterialien nach Gabe von Vitamin D3 auf einen 
Integritätsverlust der Zellmembran zurückzuführen ist, während die Kombination aus Al2O3 NM 
und Vitamin D3 zu einer Erhöhung der Membranstabilität führte. Woran genau dieser 
Unterschied liegt, konnte im Rahmen der Studie nicht abschließend geklärt werden. Allerdings 
deuten unsere Ergebnisse auf einen weiteren Forschungsbedarf hin, um aufzuklären, welche 
Eigenschaften eines NMs ausschlaggebend für die beobachteten Interaktionen sind.  
Zusammenfassend trägt die vorliegende Arbeit dazu bei, Nanomaterialien genauer 
charakterisieren und detektieren sowie ihre Interaktionen mit biologischen Systemen besser 
erklären zu können. Die vorgestellten Methodiken und Ansätze können für zukünftige 
Forschungsarbeit genutzt werden und damit zu einer sichereren und verlässlicheren Anwendung 
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CDE   caveolae-dependent endocytosis 
CME   clathrin-mediated endocytosis 
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DLS   dynamic light scattering 
EC   European commission 
EELS   electron energy loss spectrum 
EDX   X-ray energy dispersive spectroscopy 
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MDG   microdroplet generator 
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NOAL   no adverse effect levels 
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NTA   nanoparticle tracking analysis 
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SEM   scanning electron microscopy  
sp-ICP-MS  single particle inductively coupled plasma mass spectrometry  
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SPR    surface plasmon resonance 
STEM   scanning tunneling electron microscopy 
TEM   transmission electron microscopy 
ToF   time of flight 
ToF-SIMS  time of flight secondary ion mass spectrometry 
US EPA  United States Environmental protection agency 
XRD   X-ray diffraction 
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Humanity can only exist through interaction with its environment, whether it is to feed oneself, to 
establish living space or to develop over time. Especially the advancement of new technologies is 
part of a developing civilization. [1] Solving problems through technological progress leads to 
new manufacturing processes and products. However, due to their novelty, these technological 
achievements are often associated with an uncertain health risk for manufacturers and users. [2] 
Examples of technologies where concerns about their safety arose only after market introduction 
include genetically modified organisms with the CRISPR-Cas9 system [3] or fracking [4].  
 
Technologies that are considered questionable by the general public with regard to their security 
tend to spread slower and have considerable difficulties becoming widely accepted [1]. A 
comprehensive risk assessment using a “safe-by-design” approach could ultimately avoid 
negative implications for the user of a novel technology is therefore indispensable in order to 
guarantee a broad dissemination. This is the key to exploit the full potential of a technology. 
Nanotechnology is an example of a developing technology of the past decades, which is being 
discussed ambivalently due to its rapid and extended applications in various areas of daily life 
and also because of unknown risks and hazards for human health and the environment [5]. The 
following part of this work will deal with nanotechnology and NMs (NMs) in particular to 
elucidate not only the risks but also highlighting their applications.  
 
In his lecture "There's Plenty of Room at the Bottom", the famous physicist Richard Feynman 
laid the foundation for today's nanotechnology. He described ideas and concepts on how new 
substances could be synthesized by manipulating individual atoms by nanoscaled machines [6]. 
Due to technical limitations at that time, Feynmann's ideas could not be translated into practical 
use right away. Finally, the invention of characterization techniques like the atomic force 
microscopy (AFM) [7] and scanning tunneling electron microscopy (STEM) [8] assisted 
significantly in turning Feynmann's vision into reality. Using advanced analytical technologies, 
the behavior of substances at the nanoscale could be investigated.  
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The term "nanoscale" usually refers to the size range between 1 and 100 nm, which corresponds 
to one billionth of a meter (10-9 m). The smaller an object becomes, the more the volume to 
surface ratio increases. Caused by the increased surface area, the number of surface atoms rises 
exponentially with decreasing size [9]. In order to illustrate this fact further, one should consider 
the following example: The proportion of atoms on the surface of a macroscopically visible solid 
is 10-7, whereas a spherical NP (NP) consisting of 8000 atoms contains about 1600 atoms on the 
particle surface. As a result of the increased amount of surface atoms, the physicochemical 
properties of the NP changes. By reducing the size of substances to the nanoscale, not only their 
actual size changes, but also quantum physical effects occur more frequently. The cumulative 
influence of these effects leads to novel chemical, physical, optical, and mechanical properties of 
the NM [10].  
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1.1. Nano - the definition of something very small  
 
Despite the benefits also risks may be associated with the frequent use of nanotechnology in 
modern day consumer products. However, a worldwide and over all regulatory fields commonly 
used definition of “nanoparticle” or “nanomaterial” is still missing. Boholm et al. reported 36 
definitions for these two terms [11]. This illustrates the struggle of finding a comprehensive 
definition. The problem which policy makers are facing is a feasible definition of a NM in order 
to foster beneficial nano-based products but also to prevent potential hazards. Since the 
regulation of products which are not defined is not possible, the EU took action and presented the 
definition of a NM in 2011 as follows:  
“A natural, incidental or manufactured material containing particles, in an unbound state or as an 
aggregate or as an agglomerate and where, for 50 % or more of the particles in the number size 
distribution, one or more external dimensions is in the size range 1 nm - 100 nm. In specific cases 
and where warranted by concerns for the environment, health, safety or competitiveness the 
number size distribution threshold of 50 % may be replaced by a threshold between 1 and 50 %. 
By derogation from the above, fullerenes, graphene flakes and single wall carbon nanotubes with 
one or more external dimensions below 1 nm should be considered as NMs” [12].  
The European commission (EC) aimed to develop a science based definition. In contrast to the 
definition of a NM from the United States Environmental protection agency (US EPA) [13, 14], 
the EC’s definition does not differentiate whether a novel property is present due to the nanosize 
or not. The example shown is not the only difference in the various definitions. Some legislators 
distinguish whether a product is nanoscale in all three spatial dimensions and only then regulate 
it, while for others one spatial dimension in the nanorange is already sufficient. Aggregate size, 
composition and other characteristics also differ in the various definitions [15].  
Despite this diversity of definitions, a comparatively large number of them include the term 
nanoscale or even an explicit size range [16]. However, such a strict size limitation could lead to 
hazardous particles not being properly regulated. Several scientists argue that a “one size fits all” 
regulation is not appropriate for the NMs cosmos. Instead, a regulation adapted to the class of the 
material is needed [17, 18]. This is a plausible approach as the following example will illustrate. 
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A 40nm gold (Au) NP is considered to be inert [19]. However, if the size of the Au particles is 
reduced to less than 3 nm, the particles become much more reactive. This is also the reason why 
3nm Au NPs are used as catalysts [20]. According to almost all definitions, the inert particle 
would be regulated in the same way as the reactive particle. Considering this example, the 
definition and thus the regulation of such a complex concept as “NM” is difficult. Maynard also 
states that “a sensible definition has proven hard, if not impossible, to arrive at” [11, 17].  
However, the different definitions are not just pure wordplay. They also have great practical 
relevance. The fact is that a nanoproduct in the EU does not have to be one in America according 
to the US EPA definition. An increase of uncertainty among consumers as well as manufacturers 
is the result. The lack of a general definition of a NM prevents mutual regulation [11]. In the end, 
the question remains which properties, be it physico-chemical characteristics or even possible 
interactions between NM and biological systems, are suitable for an adequate definition. 




1.2. Physicochemical properties of NMs  
 
The fact that size has a significant influence on the physical and chemical properties of an object 
and that the subsequent reduction in size leads to new object properties illustrates the potential of 
NMs (see Figure 1). 
 
Figure 1 Overview of the material properties that differ from bulk to the nano form (modified from [21]) 
The following subsections will explain some of the unique properties of NMs and their 
applications in more detail.  
 
Magnetic NPs can be affected by magnetic fields. The excitation and oscillation of electrons by 
the magnetic field of light is described as surface plasmon resonance (SPR) [22]. SRP is common 
for metallic nanostructures and is hardly achievable in other physical states [23]. The application 
of SPR enables new fields of use for metallic NPs, were the amplification, concentration and 
manipulation of light are crucial [22, 24] as for the detection of cancer [25]. Furthermore SPR 
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can not only be exploited as a cancer probe but also to actually attack the cancerous tissue [26]. 
The so called photothermal therapy is also based on SPR were a heating of the tissue originates 
from the high energy absorption of metallic NPs and a subsequent energy release in form of heat 
[27, 28]. 
 
Furthermore SPR is employed in sensors which are able to detect biological molecules such as 
amyloid beta [29] or protein-DNA interactions [30]. The label free detection as well as the 
possibility to track analyte changes in real time increases the demand for SRP based nano sensors 
[31, 32].  
 
The resulting manipulation of the structure of the particles by an external magnetic force enables 
a variety of applications in a wide range of disciplines. Especially in biomedical applications 
tinier particles in the range of 10-20 nm are preferred if interaction with biomolecules is 
anticipated [21]. The targeted combination of a single magnetic NP with a biomolecule leads to 
new approaches and innovations in the field of imaging [33], targeted delivery of drugs [34] or 
the therapy of medical conditions such as cancer [35, 36]. Besides the biomedical applications 
magnetic NPs were also successfully employed to clean industrial waste waters [37] and remove 
heavy metals from drinking water[38].  
 
Due to advances in nanotechnology, NMs are becoming more frequently used in the field of 
chemical catalysis. In this context they are mainly used as a matrix to support catalytic reactions 
[39]. Due to their large surface area, they are ideal for carrying a large quantity of catalysts 
molecules on the surface of the nanoparticle [40]. Compared to conventional methods, the 
accessibility of the catalyst on nano-based systems is significantly higher than in other types of 
systems [39]. Especially the reusability of the nano based catalytic platforms renders them 
interesting for green chemistry approaches [41].  
 
The nano form also changes the mechanical properties of a material when compared to its bulk 
material, which renders them an interesting option for surface modification to enhance the 
mechanical strength of e.g. concrete or nanocomposites [42]. NPs are also used as an effective 
polishing tool [43]. 
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As already mentioned, NPs possess a high reactivity. Upon contact with biological fluids, a 
complex of layer biomolecules, such as proteins, forms around the particle [44]. The 
biomolecules compete for the binding to the particle und thus form a highly dynamic envelope, 
which defines the biological identity of the particle and is called the protein corona [45]. The 
protein corona contains different layer which are called the soft and the hard corona (see Figure 
2). The hard corona contains proteins that exhibit a high affinity for the NP and may even bind 
irreversible to the NP surface, while the soft corona contains proteins that show a rather low 
affinity for the particle and may exchange over time [46]. 
 
The protein corona influences and alters the physicochemical properties of the NM, such as the 
size or surface charge [47]. In addition to these changes the particle biodistributions as well as 
particle induced responses in biological systems are altered through the presence of the protein 
corona [44, 48]. It could be shown that NPs of the same shape and size showed altered uptake 
and accumulation behavior when different proteins were present in the culture medium [49]. 
 
Figure 2 Schematic of NP biomolecule interactions and the formation of a corona around the particle (adapted from [46]) 
The manipulation of the protein corona in order to increase the efficacy of targeted therapies was 
already employed for cancer medications. Here, the particle corona was altered with proteins or 
peptides which were overexpressed in cancerous tissue in order to enhance the targeting of the 
anti-cancer medication [50]. Since the protein corona changes the identity of the particle in many 
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different ways, it has to be considered as an important factor for biodistribution and toxicity 
assessments.  
 
In order to ultimately assess the suitability of NPs for a specific application in a product, the 
properties and behavior of the NM must be precisely assessed. For this purpose, particle 
characterization is an important tool to determine such applicability. 
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1.3. Characterization Techniques  
As stated above surface characteristics and size are often criteria for the definition of a NM. A 
comprehensive physicochemical characterization of the NM is essential to understand the 
interactions of NMs and cells [51]. However, the underlying relationships between the properties 
of a NM and the possibly toxic interaction with organisms is still limited [51]. Therefore, a 
detailed as possible characterization of the physicochemical properties of the NM is 
recommended [52, 53]. A comprehensive characterization thus contributes to a better 
understanding of toxicokinetics and the underlying principles which drive the interaction of a 
NMs and a biological systems [54]. The following part will contain an overview of the most 
common characterization techniques for NM and highlight their strengths and weaknesses. 
1.3.1. Size Characterization 
 
As already mentioned at the beginning, the particle size of a solid substance is a major element 
for most definitions of a NM. Therefore, the next section will deal with an excerpt of techniques 
that are able to characterize the size of NM. However, a distinction must first be made here 
between the hydrodynamic radius, which is made up of the actual size of the NM, an additional 
hydration layer and polymers or other stabilizers [55]. While the particle core diameter is the 
diameter of the pristine material.  
1.3.1.1. Dynamic Light Scattering 
 
Dynamic light scattering (DLS) is a technique where a laser beam is directed at a sample 
dispersion. The particles in the sample then scatter the incoming light [56]. The scattering is 
caused by a Doppler shift of the incident laser light, which is based on the Brownian motion and 
can be translated into a z-averaged translational diffusion coefficient [57]. Under the assumption 
that the NM is shaped as a compact sphere the diffusion coefficient can be transformed into the 
hydrodynamic diameter using the Stokes-Einstein equation [58].  
 
DLS is a very common method for characterizing the size of NMs. Due to the quick and easy 
handling of this non-destructive technique, the method is suitable to have a first overview of the 
particles hydrodynamic diameter size distribution of the dispersion [59]. Since the DLS is based 
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on an intensity weighted correlation function larger particles will dominate the size values over 
smaller particles which leads to biased results for multimodal particle size distributions [60]. 
Although DLS has some limitations it is a very valuable tool for a quick NP characterization. 
1.3.1.2. Nanoparticle tracking analysis 
 
Like the DLS, nanoparticle tracking analysis (NTA) is based on a light scattering sizing 
technique and determines also the hydrodynamic diameter. The sample is imaged over a certain 
period of time using a laser-based microscopy system which allows the visualization and tracking 
of the particles. The particle follows the Brownian motion and the particle velocity can be 
transformed in the hydrodynamic diameter by applying the Stokes Einstein correlation.  
 
While in comparison to DLS, NTA can be time consuming it has a better peak resolution and is 
well suited to characterize polydisperse samples. Especially the presence of very large aggregates 
has less impact on the NTA sizing accuracy since it evaluates particle by particle instead of the 
intensity weighted approach of the DLS [61]. However, since large aggregate move very slowly 
the accuracy of the NTA is decreased. Furthermore, the viscosity of the surrounding matrix 
strongly influences the particle movement and therefore is one of the limiting factors for the 
upper detection limit of the NTA.  
1.3.1.3. Single particle inductively coupled plasma mass spectrometry 
 
The previous sub-section described particle sizing techniques which are limited in their 
applicability. For example, the monitoring of environmental NP burden is often not feasible for 
light-based techniques. In detail the detection limit of these sizing methods is in the mg/L range 
[60]  while the particulate content in complex samples is often in the sub μg/L range [62]. 
Furthermore, the matrix of human samples, intended for biomonitoring experiments like blood, 
urine or saliva is often complex and affects the agglomeration and aggregation behavior of the 
NMs. Especially the characterization of polydisperse samples with light scattering techniques 
such as DLS is prone to these errors [63]. Single particle inductively coupled plasma mass 
spectrometry (sp-ICP-MS) can tackle the before mentioned issues.  
 
The sp-ICP-MS is based on a conventional ICP-MS system. The nanoparticulate sample is 
strongly diluted to a one by one particle sample introduction rate [64]. The liquid sample is then 
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transported over an inlet into the pneumatic nebulizer. The Nebulizer converts the liquid into an 
aerosol which is further transported into the plasma where the sample gets ionized. Afterwards 
the analyte, that has been focused beforehand, enters the actual mass spectrometer. The ionized 
analyte is separated and detected according to its mass to charge ratio (m/z) [64, 65]. In a typical 
ICP-MS system, a quadrupole is mainly used for this purpose, although time of flight (ToF) or 
sector field systems also exist. In contrast to the conventional measurement mode of ICP, where 
elements can be determined specifically with a high sensitivity, the sp-ICP-MS requires intensity 
measurements with a very short dwell time (<15 ms). These measurements are performed as a 
function of time, allowing the identification of above background flashes as individual particles 
[66]. The frequency of these above background signals is directly proportional to the 
concentration of particles in the sample [67, 68]. An ionic calibration standard as well as NP 
reference standard is employed to convert the intensity of the signals into the actual size of the 
particle [69]. In contrast to other characterization techniques such as DLS or NTA, influences of 
the matrix such as the formation of a protein corona are not reflected by the particle core diameter 
which is determined by sp-ICP-MS. This value refers to the actual size of a "pristine" particle. 
Within the short measuring time of a few minutes, ICP-MS allows not only the determination of 
the average particle size but also the particle size distribution and particle number concentration 
of the NPs [64]. In summary, sp-ICP-MS is a powerful tool for the analysis of NPs; however as 
in any technique there is still room for improvement for example faster scanning rates for a 
reliable analyte quantification. 
1.3.1.4. Microscopy based techniques to analyze size 
 
Currently a number of microscopy based techniques exist that are capable of analyzing NPs. 
They are not only able to generate images of NPs, but can also provide further information about 
the elemental composition and structure [60]. All microscopy methods derive their data about the 
particle properties from the recorded images. Through a suitable thresholding the resulting 
information is not affected by interference with other particles or the surrounding environment 
[70]. Meaningful information about the particles within a sample can only be obtained if a 
sufficient number of particles have been evaluated. 
 
Electron microscopy techniques are all based on the utilization of a high energy electron beam 
which is directed at the sample. Scanning electron microscopy (SEM) is a technique where the 
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secondary electrons are measured, which are created while the electron beam scans over the 
sample. Sample preparation for SEM is lengthy since the sample must be coated with either Au 
or graphite under vacuum to prevent the interactions of the secondary electrons with the gas 
molecules. SEM is capable of generating 3D datasets of the sample [60]. The high spatial 
resolution of SEM as well as the possibility to characterize NMs in all three dimensions exhibits 
the importance of SEM. Agglomerate formation can hinder the detection of single NPs within 
these agglomerates [58].  
 
Another electron microscopy based technique is the transmission electron microscopy (TEM). In 
contrast to SEM the electrons that traveled through the specimen are recorded in order to obtain 
an image. The sample preparation for TEM is challenging since the sample has to be ideally less 
than 100 nm thick, to ensure the passage of the electron beam through the sample. However, 
TEM is one of the most common technologies when it comes to the characterization of NMs and 
is regarded as the “gold standard” for the size determination of nanomaterials [71].  
1.3.2. Composition Characterization 
 
NPs are either consisting of a single constituent or are composite of several materials [72]. Apart 
from the size of a NM the actual chemical composition plays also a crucial role for the toxicity 
and the mechanisms involved in the toxicological phenomena observed [73]. For example 
cadmium containing quantum dots exhibit a strong cytotoxic behavior which is not the case for 
the non-cadmium containing counterparts [74]. Also the biodistribution within living organism is 
strongly influenced by the composition of the NM [75]. These examples highlight the need for a 
thorough composition analysis in order to foster a safe use of NMs.  
 
Standard ICP-MS has become one of the most used technique for quantification and chemical 
characterization of inorganic NMs [76]. It was demonstrated, that a prior acidification or a 
microwave digestion of the sample needs to be performed in order to achieve reliable results for 
the assessment of the NP composition [76].  
 
Another technique to investigate the sample composition is electron energy loss spectrum (EELS) 
imaging using an electron microscope. EELS is capable of providing information not only on 
spatial orientation but also on the chemical composition of particles [77]. Like all electron 
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microscopy techniques, EELS is based on the interaction of a focused electron beam with the 
sample. During the interaction of the beam with the sample the electrons are scattered. The 
electrons loose energy in the scattering process. Due to the lost energy of the electrons, the 
specific composition of the sample can then be deduced [78]. EELS are especially useful for the 
elucidation of the spatial distribution of the elements.  
 
Instead of an electron beam like in EELS, an X-ray beam can also be used to characterize the 
composition of the NM. With the so-called X-ray energy dispersive spectroscopy (EDX), a lower 
background signal can be generated, which leads to an improved quantification compared to 
EELS [71]. EDX is only suitable for thin samples but is able to detect heavy elements better. 
EELS, on the other hand, should be used for the detection of lighter elements [79]. In 
combination with TEM/SEM these two methodologies are powerful tools to analyze and 
characterize NMs.  
 
1.3.3. Surface Characterization 
 
The AFM is one of the most prominent techniques for surface characterization of NMs and it 
allows also the determination of the size and shape of an NM [80]. For this technique, the tip of a 
measuring probe is directed over the surface of the sample. During the process, the tip of the 
probe interacts with the sample, which changes the oscillation of the probe. The surface 
topography is mapped using the forces of attraction and repulsion of atoms on the surface and the 
probe. These subtle changes are detected by a laser directed at the tip of the probe and a 
photodiode array detector that records the reflections of the laser. An advantage of this method is 
the rather simple sample preparation. NPs can easily be measured directly on a flat substrate 
surface. Particle dispersions have to be applied to a wafer beforehand [81].  
 
X-ray diffraction (XRD) can be used to investigate the structural characteristics of crystalline 
samples. An X-ray beam is directed onto the sample and the resulting diffraction pattern, which is 
specific for the crystalline structure of the sample, is assessed [81]. When evaluating XRD 
experiments, however, it should always be remembered that the information obtained is derived 
from the crystallographic properties of the corresponding crystal domains [82]. Unfortunately, 
these domain properties do not always correspond to the properties of the whole particle. It is 
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therefore necessary to use additional characterization techniques like TEM to verify the results 
form XRD experiments [81]. Nevertheless, XRD is a valuable tool not only for the structural 
characterization but also for the determination of surface charge, shape and area of a NM.  
 
A technique which can be employed for the determination of the three dimensional structure as 
well as for the determination of the surface and chemical composition is the time of flight 
secondary ion mass spectrometry (ToF-SIMS). This method relies on the detection of secondary 
ions which are formed after the sample is impacted by a primary ion beam. This technology is 
especially well suited for the detailed three dimensional visualization of multiple chemicals, 
metabolites within biological samples and also for the characterization of pristine NMs and NMs 
within biological samples [83, 84]. The high lateral resolution down to the sub-micron range in 
combination with the extreme depth perception of this technique allows the visualization of cells 
as well as NMs in a high level of detail [84]. However, the long duration of the analysis and the 
rather complex sample preparation are possible shortcomings of this technology. 
1.3.4. Benefits of a comprehensive characterization 
 
The methods presented above can record the properties of NMs in detail. The further 
development of new NMs with specific characteristics as well as the reliable manufacturing of 
NMs requires inexpensive and reliable characterization methods. The advancement of existing 
techniques is therefore equally important as the emergence of new characterization techniques 
[81]. 
 
Due to the large number of modifications of NMs, comprehensive toxicity testing of all NMs is 
neither financially nor time-wise possible. In order to nevertheless make statements about the 
toxicity of a NM, they are grouped according to their physical and chemical properties. The 
biological interactions are then tested for only a few representatives of each group and the results 
are applied to the whole group [85]. However, since changing the properties of a NM alone can 
lead to altered biological interactions, grouping is a challenging process [86]. In addition, the fact 
that in most of the characterization studies the NM was examined individually is a complicating 
factor. In biological environments NMs are modified for example by the formation of a protein 
corona and thus their reactivity in biological systems may change accordingly [87]. Nevertheless 
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grouping is considered to be a valuable approach to fill data gaps, reduce animal experiments and 
provide a valid prediction tool for the safety assessment of NMs [86].  
 
A comprehensive physicochemical characterization does not only serve the purpose of obtaining 
information about a NM. Since properties of materials also steer their interactions with the 
environment, this knowledge can be used to predict the interactions between NM and the 




1.4. Biokinetic behavior of particles   
 
The versatile use of NMs opens up numerous possibilities of exposure scenarios for humans. 
Although a multitude of products contain NMs the actual knowledge about the release of NMs 
from a product is still very limited [88]. For the majority of people, air, food and consumer 
products which are contaminated with NPs represent the greatest risk of exposure. For humans 
the three major uptake routes are uptake via the dermal, respiratory and oral barrier [89]. The 
following section will deal in more detail with possible admission mechanisms into the body and 
the subsequent cellular uptake mechanisms. 
1.4.1. The dermal barrier 
 
Every substance which comes into to contact with the skin might be able to cross the dermal 
barrier, get absorbed into the skin tissue and may get systemically available. The use of NMs in 
cosmetics suggests that there might be a risk of dermal absorption.  
 
There are essentially two routes for uptake into the skin: through the skin appendages or through 
the stratum corneum. Studies which employed fluorescent polystyrene NPs were able to show 
that NPs tend to accumulate in follicular openings of porcine skin in a vertical diffusion cell. 
However, no further evidence of particle absorption was observed [90]. Although particles can 
accumulate in hair follicles this process is by definition not an uptake into the body [91]. 
Furthermore, the lower end of the hair follicles is protected by a layer of tight junctions [92] 
which remain intact upon exposure to particles. An uptake of particles through follicular 
penetration was not observed for insoluble NPs [93].   
 
The skin consists of several layers of different cell types which form a robust barrier. The 
Epidermis, which is the outermost part of the skin, is renewed every 4-6 weeks [94]. The 
continuous renewal of the epidermis can be a decisive factor in preventing the systemic 
availability of NMs [95]. The stratum corneum (SC), which forms the outermost layer of the 
epidermis, is for many substances the decisive barrier for absorption through the skin [91]. The 
brick and mortar structure of the SC offers a substance the possibility to either pass through the 
corneocytes or penetrate along the lipid matrix. The uptake by following the lipid channels 
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between the corneocytes is more likely to occur since the lipid matrix offers a channel like 
structure that facilitates the diffusion [91]. 
 
Skin penetration studies which utilized quantum dots showed increased skin penetration [91] 
while for insoluble NPs such data is quite rare. An uptake into the skin has been demonstrated for 
titanium oxide particles [96]. Scientific evidence for a systemic availability of NMs after contact 
with intact skin remains scarce [97]. However, a case report of a burn victim which was treated 
with a special burn dressing that contained silver (Ag) NMs showed elevated Ag blood plasma 
levels in the patient [98]. Studies suggest that already a mild damage like a sunburn is sufficient 
to increase the uptake of NMs which are present in skin care products [99]. These findings 
demonstrate that an impairment of the skin barrier increases the likelihood of an uptake of a NM 
into the skin.  
 
In summary, the available scientific data suggests a rather low uptake of nanomaterials into the 
intact skin. Nevertheless, a better mechanistical understanding of the cellular uptake mechanisms 
of NMs is necessary in order to achieve a reliable risk assessment.  
1.4.2. The inhalative uptake 
 
While the skin is often regarded as less penetrable, the respiratory route is regarded as a more 
relevant entry point of NPs into the body. NPs that are present in the airflow can reach the lung 
tissue during breathing and are further translocated [100]. The understanding of the underlying 
deposition mechanisms and factors which influence the deposition are crucial for a reliable risk 
assessment [101] The deposition of airborne particles depends on multiple factors, whereby the 
major ones in this context are the properties of the aerosol itself, the particle diameter and the 
inspiratory flow rate [101]. Larger particles and agglomerates, which have settled in the area of 
the upper respiratory tract, are contained in a mucus layer. Through mucociliary clearance these 
particles are now transported to the throat where they can either be coughed out or swallowed 
[102]. 
 
Particles which are smaller than 500 nm are able to travel from the extrathoracic parts of the 
respiratory tract all the way down to the alveoli mainly through diffusion [103, 104]. The alveolar 
region consists of alveolar epithelium which is formed by Type I and II pneumocytes as well as a 
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one cell layer thick endothelium and an interstitial cell layer. The small distance between the 
capillaries and the alveolus allows the exchange of gas which is driven by diffusion. A liquid film 
which is called surfactant and consists of phospholipids and surface proteins covers the alveoli. It 
enables an effective gas exchange by lowering the surface tension [105]. The surrounding tissue 
of the alveoli contains fibroblasts and macrophages. The later ones help to prevent pathogens 
from infiltrating the organism and can trigger a rapid immune response [106].  
 
The particles which reached the alveolar region are first confronted with the protein containing 
surfactant. Since NPs have the unique feature of forming a protein corona, they are able to attach 
proteins from the surfactant onto their surface. This can result in a disturbance of the particle 
clearance as well as a decrease of the surfactant production [107].  
 
Particles that have been submersed in surfactant can be taken up by lung associated macrophages. 
These macrophages play a crucial role in the elimination of the particles but are also contributing 
towards particle retention in the body [103]. Experiments in rats demonstrated the ability of 
macrophages to take up 90% of the remaining lung retained 20 nm iridium NPs in a time course 
of 72 hours [108]. After the uptake the particles are transport to the larynx, which is considered 
the major clearance mechanism for the peripheral lung regions [103]. However also the 
characteristics of the particle seem to play an important role for the macrophage mediated 
clearance. A study which employed 20 nm TiO2 NPs showed a rather low particle uptake of 0.1 
% within the first 24 hours of inhalation [109]. For microparticles of different origins the 
phagocytose rate after 24 hours is expected to be 85-90% [103]. This highlights that the particle 
size and chemical composition seem to play an important role for the clearance mechanism. 
Furthermore the data suggest, that the main clearance mechanism is much slower for nano sized 
particles and thus increases the probability of uptake into the epithelial cell layer or even across 
the epithelial barrier [103]. Experiments suggest a crossing of the epithelial barrier and a further 
translocation of the particles in secondary organs. This was shown for metal as well as for non-
metal containing particles in the size range between 5-100 nm in animal experiments [100, 103].  
 
Experiments in which healthy adults inhaled Au NPs were able to reproduce the results of the 
animal experiments [110]. Miller et al. could demonstrate a prolonged Au excretion even 3 
months after the exposure with the 5 nm Au particles. These findings suggest a systemic retention 
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and delayed excretion over the urine for the 5 nm Au NPs [111]. They furthermore could show a 
translocation of the systemically available Au NPs in atherosclerotic lesions in the human test 
subjects who had a history of ischemic stroke [111]. In summary, the results of Miller's study 
highlight an uptake of airborne NPs and their deposition in dangerous regions of the body such as 
atherosclerotic altered blood vessels. In particular, the apparently favored deposition in inflamed 
tissue should be a cause for concern since the particle mediated toxicity could worsen the state of 
the inflammation and potentially harm the organism. Unintended exposure of humans to NPs 
should be prevented when possible [111].  
 
As in the case of initial particle deposition in the lung, several properties of the particles play a 
decisive role in their uptake and further translocation into the body. It was shown that a large 
surface area, which is increasing with decreasing particle diameter as well as a negative particle 
charge are key parameters for an enhanced translocation [112]. The solubility of a NM dictates its 
retention time in the lung tissue and the subsequent clearance mechanism [100]. As already 
described earlier the protein corona of the particle also influences the particle translocation and 
the further uptake and translocation route throughout the body [113].   
 
The results of numerous studies show that although microparticles and larger aggregates of 
particles are efficiently removed from the lung due to mucocilliary clearance, NPs can 
circumvent this mechanism and are able to translocate into the body and have the potential to 
cause toxicological relevant adverse health effects.  
1.4.3. The oral uptake route  
 
Since NPs are used as food additives and in products that are in contact with food, oral intake is a 
plausible uptake route in addition to inhalation [114]. The particles are either intentionally added 
to the food product or might migrate into the food from packaging materials or during the 
cooking process and are then ingested. While it was demonstrated that a release of NMs from 
low-density polyethylene (LDPE) based food contact materials is rather unlikely [115, 116] the 
NM release from other nanocomposites might occur and has to be taken into account [54]. 
During the digestion, the particle travels through the compartments of the gastrointestinal tract 
[117]. In each of these compartments the environment of the NP changes drastically. Especially 
the pH shifts as well as the presence of different enzymes changes significantly from 
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compartment to compartment. Salts and bile acids may as well influence the properties of 
particles [118]. A change in the particle properties might result in a changed agglomeration 
behavior or even the complete dissolution of the NPs [117]. The enhanced dissolution of the 
particle and the subsequent formation of ions naturally pose far-reaching problems for risk 
assessment because the absorption of metal ions from the intestine will show significantly 
different kinetics than the uptake of particulate components. In order to elucidate the changes of 
the NP properties during the digestion process an artificial digestion procedure was used by Sieg 
et al. [117]. Their results clearly indicate a de novo formation of particles which originate from 
free ions in the nano-range as well as a dissolution of the administered particles [117]. These 
results highlight the importance of particle characterization under physiological conditions in 
order to predict the exact uptake of a NP into the body.  
 
Particle absorption is a prerequisite for the particle translocation into secondary organs. The 
decisive factor for the adsorption is the passage of the particles or ions through the intestinal 
epithelium [119]. However, before particles can enter the epithelium, they have to pass through 
the mucosa of the gastrointestinal tract. The mucosa is a gel-like fluid that covers the surface of 
the gastrointestinal tract and is therefore a barrier for both macro- and NPs. As the mucosa is 
continuously reproduced, particles contained in the mucosa are transported along the 
gastrointestinal tract and excreted via the feces [120]. Particles which were able to defy the 
mucosa are mainly absorbed by the M-cells which are in the Payers patches of the small intestine 
and also by the enterocytes of the intestine [121]. A study with non-degradable latex particles 
demonstrated that with decreasing particle diameter increases the probability of absorption into 
the cells increases. The majority of taken up particles in this study were in the size range between 
50 and 100 nm [122]. The uptake rate of particles can be further enhanced by an optimized 
composition, or by the application of ligands on the particle surface which can interact with 
receptors responsible for the uptake of substances into the cell [123]. After crossing the intestinal 
barrier, the particles are either transported into secondary organs by the bloodstream or via the 
lymph [124].  
 
 
1.4.4. Distribution of bioavailable NPs  
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From the previous sections of this chapter it is evident that NPs are capable of overcoming the 
gastrointestinal as well as the lung barrier and thus become systematically available. Only the 
intact skin seems to be a rather insurmountable barrier for NPs. The following section describes 
the distribution and accumulation of NPs in the body. 
 
After the NPs enter the blood stream they are in contact with the constituents of the blood [125]. 
Since NPs can form a protein corona, this protein corona may now change depending on the 
interactions with various blood constituents. The resulting formation of the protein corona will 
significantly increase the NPs size compared to the pristine particle [126]. The particle will then 
be transported through the body by the blood circulation. Its half-life time in the circulation 
depends strongly on its size. Particles smaller than 5 nm can overcome the endothelial barrier 
much faster than larger particles and show a prolonged circulation half-life time compared to 
larger particles [126]. Besides size, surface modification plays a major role in the biokinetics of 
the particles. It has been shown that pegylation significantly alters the half-life in blood and 
influences the distribution patterns in secondary organs significantly [127]. By specific surface 
modification it is therefore possible to vary parameters which are particularly important for the 
therapeutic application of NPs [127]. Another parameter which seems to contribute to the half-
life time in blood is the surface charge. Arvizo et al. were able to demonstrate that negatively or 
positively charged NPs exhibited shorter circulation half life time compared to neutral ones 
[128]. 
NPs are hence capable of leaving the blood stream over time. Animal studies have shown that the 
majority of particles are found in the liver and spleen [100]. However, more specific information 
about the target organs and tissue distributions of metallic NPs is scarce and a clear need for 
research exists [129]. Moreover, there are also differences within the group of metallic NPs, 
which further complicates the problem. For example, the biotransformation of metallic particles 
that easily dissolve and form ions such as Ag differs from that of those that are rather insoluble 
like Au based NPs [129].  
1.4.5. Cellular uptake mechanisms of NPs 
 
After a NM has left the bloodstream and migrated into a tissue, it can be absorbed into the cell. In 
general, the uptake of NMs follows a common pattern. The material reaches the outer cell 
membrane, interacts with it and is absorbed by an endocytosis mechanism [130]. Endocytosis is 
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an uptake process in which the cell membrane encases the object, resulting in the incorporation 
and formation of an endocytotic vesicle. A distinction is made between different endocytosis 
pathways which can be differentiated according to cell type and involved components [131].  
1.4.5.1. Phagocytosis  
 
Phagocytosis is primarily but not exclusively performed by macrophages, dendritic cells, 
monocytes and neutrophils as part of the immune response and of the removal of cell debris 
[130]. Opsonization, a process of tagging an object by immunoglobulins, components of the 
blood or complement system is required before phagocytosis can occur [132]. This tagging 
process enables the object identification via receptor ligand binding and subsequently it is 
incorporate into the phagosome [133]. Similar to all previously mentioned interactions of NMs 
and organisms, the physico-chemical properties play a key role in the whole uptake process. It 
has been shown that agglomerates and larger particles in the range between 1000 and 2000 nm 
are preferentially taken up by macrophages by means of phagocytosis [134]. Particles that can 
form a protein corona due to their charged or hydrophobic surface are more likely to be 
opsonised than particles that do not have this features [133]. Opsonisation can be prevented by 
PEGylation and other surface modifications, which prevent the interaction of biomolecules with 
the surface of particles [135].    
 
1.4.5.2. Clathrin-mediated endocytosis 
 
Cells depend on the absorption of nutrients and lipoproteins from their environment to maintain 
their homeostasis. Clathrin-mediated endocytosis (CME) is the regarded as the main uptake 
pathway for those substances [136]. This type of absorption takes place at Clathrin-rich regions 
of the plasma membrane. The uptake mechanism can either be receptor mediated or receptor 
independent. After the particle agglomerate has reached the cell, Clathrin and other accessory 
proteins form an invagination in the plasma membrane and facilitate the uptake of the cargo into 
the cell [130]. Investigations have shown that particle agglomerates taken up via this route often 
end up in degrading lysosomes [137]. Both surface modification and charge influence the 
preferential uptake by the cell. It could be shown that both poly(ethylene glycol-co-lactide) [138] 
and D,L-polylactide (PLA) [139] modified NPs are absorbed into the cell via CME. If the CME 
uptake is blocked by inhibitors, the uptake into the cell was significantly reduced in cell culture 
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systems. The charge of the particle not only influences the preferential uptake route but also their 
further intracellular metabolization [130]. Positively charged NPs are strictly taken up by CME in 
HeLa cells while anionic particles demonstrated an uptake over either CME or caveolae-
dependent endocytosis [138]. 
 
1.4.5.3. Caveolae-dependent endocytosis  
 
Caveolae-dependent endocytosis (CDE) is another important uptake pathway for NPs. From a 
physiological point of view, CDE is relevant for the regulation of lipids and membrane 
components as well as for signal transduction [130]. Caveolae are membrane areas with a size of 
about 50-80 nm which are lined with caveolin. After binding of the particle agglomerate, the 
membrane is inverted and a vesicle containing the absorbed cargo is constricted [140]. 
Subsequent lysosomal degradation can be bypassed by some particles, rendering CDE uptake a 
preferential target for gene or protein based therapies [141]. 
 
1.4.6. Exocytosis of NPs  
 
While the different endocytosis mechanisms and ways to exploit them for therapeutic options are 
in the focus of research, the exocytosis of particles remains largely unexplored. NPs located in a 
lysosome can be transported via an active transport into the periphery of the cell and either taken 
up by another lysosome or released from the cell by exocytosis [142]. It has been shown that 
particles leaving the endocytic vesicle or the lysosome and are thus present in the cytoplasm are 
excreted significantly slower than particles in such a vesicle [143]. The exocytosis process itself 
relies on cholesterol and sphingolipid rich membrane domains as excretion sites [144]. After 
leaving the cell these particles can than enter other compartments of the body for example the 
brain by penetration of the blood brain barrier and may cause toxicity [142, 145]. It was 
demonstrated that exocytosis rates of particles with the same physicochemical properties differ 
from cell line to cell line [142].  
1.4.7. Clearance of NPs contained in the blood stream 
 
A major part of the particles that reach the blood stream is excreted in the course of time, 
provided the particle has not left the blood stream. Renal clearance followed by urinary excretion 
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is one of the major excretion pathways for particles that entered the bloodstream [126]. As 
already described for the uptake of the particles, the physicochemical properties are also decisive 
for the elimination. A study that used quantum dots to investigate renal clearance has shown that 
renal clearance is possible for particles with a hydrodynamic radius smaller than 8nm [146]. 
These results are consistent with data on renal protein clearance, therefore there seems to be no 
particular nanospecific clearance mechanism [126]. Apart from the primary particle size, the 
charge of the particle plays a crucial role. Anionic or cationic particles have demonstrated the 
ability to adsorb serum proteins and form a distinct protein corona. The adsorption leads to a 
substantial increase of the hydrodynamic radius and thus may reduce renal clearance [146]. Once 
the particles have been successfully excreted into the primary urine, resorption of the particle in 
the proximal tubule may occur. Unfortunately, there is no reliable data on the behavior of 
particles in the proximal tubule. Since the kidney and especially the tubule epithelium is a 
preferred target for heavy metals, there is an urgent need for further research [126]. 
 
NPs that have reached the blood stream can also be removed from systematic circulation through 
the liver. Due to the high blood perfusion and fenestrations in the endothelial cells of the liver, 
NPs tend to passively accumulate in liver tissue [147]. In the tissue of the liver, the particles 
encounter hepatocytes or Kupffer cells. Kupffer cells are differentiated macrophages of the liver, 
which can phagocytize and degrade foreign matter such as particles [148]. However, particles 
that cannot be degraded by macrophages remain in the cell and thus also in the body. Any 
particles that have been taken by hepatocytes through endocytosis can be degraded enzymatically 
and then excreted through the bile [126]. 
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1.5. Toxicity of NPs   
 
It is assumed that the physico-chemical properties determine the interactions of the particles with 
their environment and thus also define the toxicity of the particles [149]. In the beginning of this 
thesis, the different physico-chemical parameters of NPs were described in detail as well as 
methods for the appropriate investigation. In the following section the different modes of particle 
induced toxicity will be investigated further.  
 
The size of the particles is obviously a crucial parameter for particle toxicity. As mentioned in the 
previous chapters, size is a decisive factor for the biokinetics of the particle. The particle surface 
area increases with decreasing size. Due to the increase in surface area, increased interactions of 
the particle surface with the surrounding environment of the particle are possible [150]. It has 
indeed been proven that the surface area of a NP is most predictive for particle associated acute 
toxicity in lung tissue [151]. The surface charge of a NM determines not only the formation of 
the protein corona and the subsequent biodistribution of the particle agglomerate but also the 
toxicity of a particle. In general a positive charged particle tends to exhibit a stronger toxic 
behavior [152]. Whether this behavior is due to an enhanced uptake or an altered biodistribution 
profile remains unclear. Lastly the shape of the particle also plays a decisive role for the overall 
toxicity of a NM, as the example of carbon nanotubes illustrates. Similar to asbestos, increased 
inhalation of the fiber like carbon nanotubes leads to chronic inflammation of the lung tissue 
[153]. In addition to the numerous in vivo studies which were able to explore the relationship 
between the inherent particle properties and the caused toxicity, in vitro studies were also 
conducted to elucidate the underlying toxicity mechanisms in cellular compartments. 
 
One of the best studied NP related toxicity mechanisms is the generation of reactive oxygen 
species (ROS) by metallic NPs [149]. A direct correlation between the inhalation exposure to 
metallic NPs, the resulting production of ROS and proinflammatory reactions could be 
demonstrated [154]. Under physiological conditions, small amounts of ROS are produced in 
cells. For example, ROS are formed as by-products in the mitochondria during the energy 
metabolism. These ROS can inflict damage to lipids, proteins and nucleic acids [149]. They are 
therefore not only able to severely damage cellular structures such as mitochondria but also to 
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disrupt the functionality of proteins [155] With the help of antioxidants such as glutathione 
(GSH) system and antioxidant enzymes, these physiological occurring small quantities of ROS 
can be quickly and effectively eliminated before damage to cellular structures is dealt [154, 156]. 
However, exposure to NPs and the resulting ROS cascade can deplete the antioxidative capacity 
of the cell. Consequently, GSH is completely diminished and the concentration of the oxidized 
form of glutathione is rising. This circumstance is also known as oxidative stress [154]. Cells 
which are exposed of oxidative stress for a prolonged period of time often die to the increasing 
damages of the ROS. Cell membranes become damaged and the membrane integrity is disrupted 
which results in a loss homeostasis [157]. DNA damages occur in higher frequencies which 
exceeds the capacity of the DNA repair machinery [158] and leads to cell cycle arrests and the 
induction of apoptosis [149]. 
 
Furthermore, NPs are able to reduce the membrane potential of mitochondria. This damage 
massively disrupts the energy production of the cell and it is very likely that these cells will enter 
apoptosis. This mechanism has been successfully demonstrated for various cells and NPs [149]. 
 
The interaction of NPs and proteins may change the protein conformation and hamper their 
functionality [159]. The unfolding of the protein structure might also cause accessibility of 
beforehand hidden protein motives. Those newly exposed motives can trigger a broad range of 
unsolicited cellular replies. For example Au NPs were capable of binding and unfolding 
fibrinogen which in turn activated THP-1 cells that released a proinflammatory response [160]. 
Other studies showed that NPs were capable of inducing fibril formation [161] which is a key 
event in the development of neurodegenerative diseases such as Alzheimer or Parkinson disease 
[159]. In addition to the before mentioned mechanisms, metalloproteins are a target for metallic 
NPs. The metallic ions interact with the metals bound within the protein and are able to severely 
hamper the functionality of the metalloprotein [162].   
 
The toxicity mechanisms mentioned above are able to cause enormous damage in the cell. 
However, exposure to NPs does not always lead to the induction of apoptosis or even necrosis 
[163]. It is also possible that the inflicted damage to proteins, DNA and cell membranes leads to a 
cell cycle arrest [149]. Minor damages may be fixed with the help of cellular repair mechanisms 
while irreparable cell damages will lead to the induction of apoptosis or even necrosis [164]. 
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Cells which are contained in cell cycle arrest do not undergo proliferation. The suppression of 
cellular proliferation is another mode of NP toxicity [149]. 
 
The above mentioned toxicity mechanisms can be influenced by the physico-chemical properties 
of the NMs. The complete elucidation of these processes will enable the development of safe 
nanoproducts. However, there is still much research needed to understand the underlying 
relationships between NPs and biological systems [165]. 
 
Comprehensive material characterization is the first step in understanding the interactions 
between NMs and the biological system. There is still a great need for knowledge in order to 




2. Aim of this thesis 
 
Nanotechnology offers the possibility to provide novel products and innovative solutions. The 
areas of application of nanotechnology are diverse and cover all aspects of life. In my opinion, 
this technology has the potential to solve existing problems, be it the improvement of energy 
storage, the advancement of catalysis reactions or the targeted application of pharmaceutical 
agents. However, all these solutions are accompanied by new hazards regarding the safe use of 
these products. The overarching aim of this thesis is to contribute towards the understanding in 
which NP interactions can be studied and thus ensure a safe and effective use of this technology.  
 
As already explained in the introduction, the definition of a NM refers primarily to one 
parameter: Size. While size definitely contributes to several biokinetic properties, there is a 
variety of techniques available to determine the actual particle size. A further development of 
existing techniques can contribute to an improvement in the accuracy of particle characterization. 
Within the scope of this thesis a sp-ICP-MS based size distribution characterization approach was 
implemented in order to expand and improve the available methodology for NP characterization 
(chapter 3.1). 
 
NMs are widely used in food and food contact materials. Further research is required to 
determine the risk of such substances, especially regarding the uptake and the distribution within 
the body of a NM. Therefore a 3-day oral uptake study was conducted with a special focus on the 
secondary organ distribution and the difference in bioavailability of the two administered 
aluminum species (chapter 3.2). 
 
In addition to the oral uptake in vivo experiments, it is essential to gain deeper insights into the 
underlying interactions of particles with cells and cell organelles. In the chosen experimental 
setup human keratinocytes were exposed to the same two aluminum NPs that were already used 
in the conducted 3-day oral up take study. Further insights into NP distribution and membrane 
changes induced upon exposure in combination with the application of bioactive substances were 
the goal of the study. The results improve the understanding of adverse effects that particles 
induce and they might also lead to the development of safer nano-based products (chapter 3.3). 
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The enhancement in the three major pillars for NM risk assessment: physicochemical 
characterization as well as toxicological data from in vitro experiments and lastly also from in 
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4. Discussion  
 
The following section comprises a detailed result discussion of the presented work.  
4.1. Enhancement of the sp-ICP-MS methodology  
 
Size characterization of NPs using sp-ICP-MS is one of the most frequently used applications of 
ICP-MS. For an effective ionization of the sample by the plasma, a suitable sample introduction 
system must be used. In order to achieve optimized ionization for single particle ICP-MS a 
pneumatic nebulizer (PN) is applied in most of state-of-the art ICP-MS instruments, but it must 
be noted that only a fraction of the sample reaches the plasma after passing through the PN. To 
adequately account for this loss, the PN based system must be calibrated using a certified 
reference size standard in order to assess the so-called transport efficiency. The use of such a 
certified reference standard has certain disadvantages. For example, the number of available size 
standards for NPs is very limited, which leads to the use of standards that do not match the 
ionization capability of the particle to be analyzed. In addition, PN based systems also have 
multi-particle events per dwell time, which further increases the measurement uncertainty of this 
methodology. In the presented publication, the use of a size reference standard was circumvented 
by using a microdroplet generator (MDG) as sample introduction system. However, MDGs are 
not without any disadvantages either, the system must be elaborately aligned, and the necessary 
parts must be adapted to the respective device in a laborious process. A dual inlet system 
consisting of PN and MDG have already been presented in previous work by Ramkorun-Schmidt 
et al. with the aim of exploiting the advantages of both sample introduction systems [166]. 
However, the construction they presented had a considerable room for improvement. 
 
First, we succeeded in designing a dual interface which can be implemented using standard parts 
normally available in a routine ICP-MS laboratory [65]. Therefore, our approach saves additional 
costs and is easily adaptable to every ICP-MS device. The design of Ramkorun-Schmidt et al. 
enabled them to combine both sample introduction systems, however, lengthy washing steps 
between samples had to be performed to avoid clogging or contaminations. By using flexible 
tubings and suitable carrier gas flows we were able to improve these deficiencies significantly 
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and therefore guarantee a continuous sample introduction flow over time, which significantly 
reduced overall analysis times for each experiment. In contrast to other approaches, the system 
developed by us does not have to be disconnected from the ICP-MS system in between samples. 
It can therefore be cleaned by applying rinsing solutions without shutting down the ICP-MS 
device. Compared to similar systems our system has a great potential to save costly analysis time, 
since shutting down and restarting an ICP-MS is a time-consuming process and would also 
require additional tuning steps to guarantee comparability between the measurements. 
 
Although Ramkorun-Schmidt et al. demonstrated the accurate determination of particle sizes as 
well as metal mass fraction using the dual inlet system, they utilized just one way to analyze their 
data. We have approached this issue and implemented further data analysis modes in our study, 
which are based on the use of the respective sample introduction systems. Finally, we succeeded 
in creating an ICP-MS based measurement procedure where a NP dispersion can be characterized 
within a single 20 min run by using three different data analysis modes. Within the scope of our 
study, we used the developed setup to characterize three different NPs: Au 56nm, Ag 75 nm and 
the polydisperse CeO2 10-100nm. In brief the run consists of 4 consecutive measurements, 2 for 
the ionic and 2 for the particulate solution. First an ionic solution is measured using the MDG and 
afterwards the PN. In the next step the actual particle containing solution is introduced into the 
ICP-MS using the MDG and finally the PN. 
 
For the actual data analysis and interpretation, we compared three different modes. Each mode of 
analysis is based on a unique combination of operation and calibration procedures, which will be 
briefly discussed below. Mode I is the widely used approach for sp-ICP-MS characterization of 
NPs developed by Degueldre et al. [67]. In this mode only the PN is used as the sample 
introduction system for the ionic as well as the particulate solution. Accordingly, a reference 
standard must be applied in order to determine the transport efficiency of the system. For the NPs 
of Ag and Au we were able to determine diameter and particle number concentrations, which 
differed minimal from the manufacturer's specifications. The good agreement for these two 
particles proves that our developed setup does not affect the measurement process itself. For the 
polydisperse CeO2, which has a size distribution between 10 and 100 nm, we obtained a mean 
particle diameter of 61.9 nm. This deviates significantly from the mean particle diameter of 28.4 
nm of the manufacturer which was determined by TEM. As we were able to show such a 
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deviation in all three modes of analysis, the evidence points to an agglomeration of the sample. 
However, the determined mean particle diameter is within the defined size range of the CeO2 
dispersion.  
 
In analysis mode II an ionic solution is introduced in the ICP-MS using the MDG as well as the 
PN and a particulate solution is later measured using the PN. This approach was developed by 
Ramkorun-Schmidt et al. [166]. It utilized the signal which the ionic solution generates while 
being introduced over the MDG to determine the ICP-MS response factor. This factor is then 
used to convert the ion intensity per NP into the metal mass per NP. We applied this 
methodology and obtained similar results as with analysis mode I. The results for Au and Ag NPs 
are in good agreement with the manufactures data, however for the polydisperse CeO2 NPs we 
obtained an even higher mean particle diameter of 70.6 nm. Agglomeration of the particles in the 
suspension is most likely the reason for our findings. However, the use of analysis mode II also 
has a decisive disadvantage. In order to determine the transport efficiency of analysis mode II, 
which is necessary to calculate the mass of the particle and thus its size, the nanoparticulate 
sample must be digested [166]. This is called the ion intensity approach for transport efficiency 
determination. Such a digestion procedure is often very labor intensive and time consuming 
especially for very insoluble metals and metal oxides like titanium.  
 
In order to overcome this obstacle, we utilized the high transport efficiency of the MDG which is 
ensured in our setup due to the application of a helical makeup gas flow. The MDG derived 
transport efficiency of approximately 100% allows the determination of the transport efficiency 
of the PN. The mass sensitivity obtained by the PN divided by the mass sensitivity of the MDG 
results in the transport efficiency of the PN. In analogy to the use of mass sensitivities, this 
approach for the determination of the transport efficiency was referred to as the sensitivity 
approach. The results obtained by the sensitivity approach are alike to those of the other two 
modes and therefore show the reliability of this methodology. The major advantage of the 
sensitivity approach is its applicability for any element detectable by ICP-MS with no 
requirement for a referenced size standard. As a result, the sensitivity approach is very versatile 
and, since no special standards are required, it should be the first choice for characterizing NPs 
for which no referenced size standards are available. 
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For analysis mode III the ionic as well as the particulate sample is introduced over the MDG 
while the PN transports a constant stream of 0.5% HCl into the ICP-MS. This approach was 
already described in detail by the group of Günther and colleagues [167]. The transport efficiency 
in this approach is also known to be 100% since a MDG is used. The results for the investigated 
Au and Ag NPs are again in agreement with the manufacturer whereas for CeO2 a mean diameter 
of 74.4 was determined. The results obtained via Mode III are equal to the results of the other two 
modes.  
 
The aim of the study is certainly not to prove the superiority of one mode of analysis over the 
other but rather to encourage the use of all three modes and to compensate the respective 
strengths or weaknesses of the sample introduction systems and thus contribute to an improve 
characterization of NMs. However, in some cases there may be NMs where high transport 
efficiency is necessary for their detection due to low sample volumes or concentrations. In 
addition, a reference material-free characterization of the NM offers an increased reliability of the 
results. 
 
For a further improvement of the sp-ICP-MS methodology it is essential to account for sample 
matrix effects in the characterization process. The matrix has a direct influence on the accuracy 
of the characterization and may therefore lower the accuracy and reliability of the 
characterization. Therefore, it would be desirable that in the future comprehensive studies are 
carried out with the objective of finding the most suitable approach for sample introduction and 
the corresponding mode of analysis. The results of such studies can contribute to a rapid and high 
throughput analysis of real samples.  
It is also worth mentioning that our instrumental equipment only allows for a single-element 
analysis of the NPs. However, since the use of NPs consisting of several elements is increasing, 
the application of an ICP- time of flight (ToF)-MS due to higher scan rates and the resulting 
higher mass accuracy is required for a simultaneous detection of those elements. It is expected 
that our setup would also be applicable for a multi element analysis on such an ICP-ToF-MS.  
The influence of matrix effects does not only have a decisive impact on sp-ICP-MS analytics. 
Chapter 4.2 will provide an in-depth look at the influence of organic matrices on the detection of 
aluminum NPs in rats as well as their tissue distribution following oral administration. 
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4.2. The oral uptake of aluminum NPs 
 
Health concerns arise whenever limit values for hazardous substances are almost exhausted or 
even exceeded. Dependent on their composition and the degree of exposure, NPs contribute to 
the total human exposure burden. Increased use of nanotechnology may therefore result in the 
exceeding of such limit values. The question of whether NPs lead to higher human exposure in 
comparison to ionic compounds is mostly unresolved. At the moment the nanoform is not taken 
into account for any threshold values for hazardous substances.  
 
In the study presented in this thesis, aluminum-based NPs (Al0 20 nm, Al2O3 20 nm) and the 
soluble AlCl3-6H2O were applied. Aluminum represents a potentially hazardous element which is 
applied in consumer products, food additives and packaging [168]. Due to its advantageous 
properties, nanoscaled aluminum applications for consumer products are on the rise. Increasing 
exposure of consumers to aluminum is a cause for concern, as an association between enhanced 
aluminum exposure and neurodegenerative diseases such as Alzheimer's have been discussed in 
the past years.  
 
Reliable information about the biokinetics of nanoscaled aluminum is also still sparse. In order to 
further promote the scientific discourse, a 3-day oral gavage in study was performed in the frame 
of the SolNanoTOX project. Aluminum-based NPs were selected for exposure of Sprague 
Dawley rats. An oral uptake via gavage was chosen as the route of exposure, as it was 
demonstrated that the oral route accounts for the majority of the absorbed aluminum within the 
human body [169]. 
 
However, before discussing NP tissue distributions in more detail, it is important to review the 
ICP-MS methodology which was used for the quantification of aluminum. As aluminum has a 
high background presence due to its ubiquitous occurrence, a fairly high aluminum background 
value was expected. A high background level might result in a non-detection of the treatment 
derived aluminum. Preliminary experiments showed an organ-dependent variance of the 
aluminum load. In our opinion, these fluctuations are due to organ matrix effects interfering with 
the analyte and thus contribute to signal suppression or signal enhancement [65]. The application 
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of a matrix calibration in combination with a daily response factor led to a compensation of the 
matrix effects and the daily sensitivity fluctuations of the ICP-MS analysis. With the help of this 
methodology we were able to quantify the aluminum organ burden in the low µg/g range. The 
results of our experiments suggest, that a matrix calibration procedure should become the 
standard methodology for ICP-MS based studies with a high matrix load in order to achieve 
higher sensitivity and increased robustness in the measurement of ubiquitous elements.   
 
In the context of the study adsorption of both of the aluminum-containing NMs and the ionic 
AlCl3-6H2O was demonstrated into secondary organs such as liver, kidney and spleen. Compared 
to inhalation studies with aluminum NMs, our results show that these NMs maintain an uptake 
via the oral route [170]. These findings indicate differences between the exposure routes within 
the same NM group and the relevance of oral uptake for aluminum containing NMs. 
 
A comparison of the aluminum content after exposure to the two aluminum NMs of intestinal 
tract (colon, duodenum) with the other secondary organs indicates significant differences in the 
aluminum accumulation behavior. Al2O3 showed a concentration dependent increase in the 
intestinal organs, while for Al0 NM a dose independent constant distribution ratio could be 
observed. Furthermore, the distribution within the duodenum and colon also differs significantly 
between the two aluminum NMs. We attribute these results to an altered agglomeration behavior 
of the Al2O3 NMs, which was further enhanced by physiological conditions such as a pH change 
between the stomach and intestinal tract. Increased agglomeration thus leads to increased 
accumulation in the gastrointestinal tract and to a reduction of the aluminum uptake through the 
gut-blood barrier. These results impressively demonstrate that agglomeration behavior in 
physiological environments is also a parameter to be accounted for in toxicological studies. 
 
After overcoming the intestinal barrier, both NMs showed a significantly increased blood 
concentration compared to the ionic AlCl3-6H2O. In this process, the two rather poorly soluble 
NMs seem to form a protein corona which delays the exchange of aluminum from the blood into 
the tissue. Such interactions of high molecular weight molecules where already reported by Sieg 
et. al. and further substantiate our results [168]. 
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Between the two NMs we also found differences in organ distribution. In each organ studied, the 
rod-shaped Al2O3 NMs were significantly more abundant than the spherical Al0 NMs. The shape 
of the particles seems to have a decisive influence on the retention time in the tissue and the 
subsequent elimination from the organism. A similar behavior was observed for SiO2 NMs with a 
circular or rod-like shape was observed in a 7-day rat study [171]. Possibly, the larger aspect ratio 
of the rod-shaped NMs may complicate exocytosis, which results in tissue accumulation and 
retention, an effect we have observed.   
 
Besides the parameters mentioned above, the chemical composition of the NPs may also be one 
reason for the difference in the translocation behavior. Although both NMs administered are from 
the group of aluminum-containing NMs, they differ in their structure and aluminum content. 
While Al2O3 is fully oxidized, the Al0 NMs consist of a core shell structure with a 2-5 nm thick 
oxide layer. As the surface composition of a NMs is crucial for the expression and structure of 
the protein corona, these differences in composition might also lead to differences in the formed 
protein corona. This is supported by in vitro studies of CaCo 2 cells that have shown that the 
protein corona of Al0 NMs was significantly less complex than the corona of Al2O3 NMs [168]. 
The observed differences in the translocation of the two NMs can also be caused by the 
differences in the surface composition and the resulting differently complex protein corona. 
 
The findings of this study impressively demonstrate that not only the size of a NM has an 
influence on interactions with a living organism. The shape, the surface properties and also the 
agglomeration behavior of a NM can influence the fate of a NM as well. Our data indicate a 
collective contribution of all physico-chemical characteristics of the chosen NM to the 
translocation behavior of a NM into secondary organs. The proportion of the respective 
parameter on the overall translocation rate could not be determined up to now.  
 
Our study shows significant differences in the translocation between aluminum-containing NMs 
and ionic aluminum. From the available data, it is not possible to draw a conclusion for the limit 
values. However, it seems reasonable to differentiate between ionic and particulate aluminum in 
future risk assessment approaches at least for pristine aluminum and aluminum oxide. 
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The time which is required for such studies has been extensive. In the light of the continuous 
development of nanotechnology, it is impossible to subject every single NM to a detailed 
examination. In order to guarantee a safe application of NMs, it is essential to determine the 
particle properties that have the greatest influence on the uptake and translocation into secondary 
organs. With grouping strategies and read across approaches it is subsequently possible to close 
knowledge gaps and ensure the safe application of nanotechnology for humanity and the 
environment.  
 
However, mechanistic insights about the modes of action of NMs within cellular systems is still 
lacking in order to successfully implement such grouping approaches. In vivo experiments are 
only of limited suitability for such studies due to the high complexity of the living organism. In 
the following chapter I would like to discuss the results of the in vitro study on the intracellular 
uptake of aluminum NPs.  
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4.3. Cellular uptake and distribution of aluminum NMs and the influence of 
co-exposure to vitamins 
 
Current toxicological research is focused on the effects of single substances, which are tested for 
toxicological endpoints like LD50 values or no adverse effect levels (NOAEL`s). However, in 
daily life scenarios the consumer is more likely exposed to mixtures of substances at low-dose 
levels then to high concentrations of a single compound. Therefore, the consideration of 
combinatorial effects like additive or synergistic interactions in substance mixtures is a 
paramount prerequisite for a reliable human health risk assessment. As a model for a multiple 
exposure setting, in vitro systems are usually better suited due to their considerably lower 
complexity than the classical in vivo experiment in order to gain mechanistic insights. 
 
In order to tackle this issue, we investigated potential non-additive combinatorial effects of 
chemicals in mixtures in the presented study. As already described in chapter 4.2., aluminum and 
aluminum based NMs are often used in consumer products and especially in cosmetics for 
example tooth paste or lipsticks [172]. The skin is the major application area for cosmetics; hence 
we applied the human keratinocyte cell line HaCaT as in vitro model for the exposure of Al0 and 
Al2O3 NMs. In addition to the aluminum-containing NMs from chapter 4.2, retinol (vitamin A) 
and cholecalciferol (vitamin D3) were co-exposed to HaCaT cells to mimic the exposure of 
multiple substances to the skin. By understanding the mechanisms of uptake and deposition of 
NMs in combination with bioactive substances on this process, important insights into safe 
applications of NMs can be gained. 
 
Within the study ICP-MS was used to quantify the cellular uptake of the different aluminum 
species. Interestingly, the results showed no influence of the two vitamins investigated on the 
cellular uptake of Al0 NM. However, the coexposure of Al2O3 NM and each vitamin alone or in 
combination, resulted in a significantly reduced uptake of the Al2O3 NM. As already discussed in 
chapter 4.2, the differences in the uptake of NMs are most likely the result of the different 
physico-chemical properties of the materials, which drive the biological interactions. In 
particular, the complexation and aggregation behavior and the shape of the NM differ 
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significantly from one another and could therefore be decisive for the preferred endocytosis 
pathways. 
 
High resolution ToF-SIMS images were acquired to further investigate the absorption behavior of 
the NMs and the influence of vitamins A and D3 on uptake and metabolic pattern changes 
thereafter. This technique is particularly suitable for the visualization of chemical distribution 
patterns with both, a high lateral resolution down to ca. 80nm and a high depth resolution for 3D 
chemical images down to 10nm. It allows the reconstruction of cells, their metabolites and the 
absorbed NPs to be visualized qualitatively. 3D reconstruction of single cells demonstrated an 
altered intracellular distribution pattern for the two applied NMs. While Al0 NMs are stored in 
larger agglomerates in distinct areas within the cell, Al2O3 uptake resulted in the formation of 
smaller agglomerates which are localized throughout the cytoplasm. The addition of retinol in the 
exposure scenarios for Al NMs led in the case of Al0 to the formation of even larger 
agglomerates, which were located in close proximity to the cell membrane. Since retinol is 
known to induce the formation of collagen fibers [173] they could serve as an interaction partner 
for the Al0 NMs and be therefore responsible for the observed localization pattern. The addition 
of vitamin D3 facilitated an enhanced uptake of the Al0 NMs as well as the formation of smaller 
agglomerates compared to the treatment with Al0 alone or in combination with retinol. These 
findings are in contrast to the results of the exposure of Al2O3 in combination with either vitamin 
which led to a decreased Al uptake into the cell.  
 
A closer analysis of the cell membrane components of the HaCaT cells was carried out to identify 
the underlying mechanism for the altered uptake and aggregation behavior of NMs within the 
cell. We identified an increase of diacylglycerols (DAGs) and phosphatidic acids (PAs) following 
the treatment of either Al NM. These metabolites serve as activators of the protein kinase C 
signaling pathway [174]. Recent studies have demonstrated an altered shape as well as a strong 
intra-cellular morphological changes for HaCaT cells after protein kinase C inhibition [175].  
 
The phosphatidylcholine (PC) to phosphatidylethanolamine (PEs) ratio was significantly 
decreased in cells coexposed with vitamin D3 and Al0. In vivo experiments have shown the 
suitability of this ratio as biomarker for the induction of a leaky membrane [176]. We therefore 
concluded that the enhanced uptake of the Al0 NMs is attributed to a passive diffusion which is 
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enhanced due to the loss of integrity of the cell membrane. Our data suggest that the interaction 
of NPs with bioactive substances can strongly influence the uptake and distribution of NPs. 
 
The coexposition of vitamin D3 and Al2O3 led to an increased production of dihydroceramides. 
These sphingolipids are known to increase the rigidity of the plasma membrane. A changed 
membrane rigidity will subsequently result in a decrease of the passive diffusion through the 
membrane as well as alterations in the active transport and vesicle formation [177]. These 
findings are in line with the findings observed in this study, that Al2O3 NM uptake was 
significantly reduced in contrast to Al0 NM uptake in HaCat cells. 
 
Our results indicate that depending on the chemical composition of the NM and the bioactive 
substance the cellular response is altered [174]. However, observed changes are not necessarily 
identical for both NM species as the results of the Vitamin D3 treatment showed. Whether the 
properties of the NM are responsible for the cellular reaction or perhaps their uptake path could 
not be clarified in this study. However, the results suggest that the metabolites of the protein 
kinase-C pathways in combination with membrane lipids are a possible biomarker for NP 
exposure and uptake.  
 
The results of the study clearly show the need to acquire more data and gain more insights into 
the co-exposition of nanoparticles and bioactive compounds. The elucidation of the influence of 
chemical composition and surface chemistry in combination with bioactive compounds on the 
uptake and the associated change of metabolic cell membrane lipid patterns is of high importance 
for a reliable risk assessment. Although it was not possible to fully explore the mechanisms 
involved in the observed metabolic changes, the study shows starting points that can be used for 
future research. Further mechanistic studies can contribute to the explanation of the principles  





5. Conclusion and Outlook  
 
Nanotechnology has the capability to enhance many aspects of life, from the development of new 
products to their use in novel disease treatments. However, given the great potential of this 
technology, there still remains a possible health risk for humans or the environment from this 
technology.  
 
The comprehensive characterization of NMs is generally regarded as the key for deeper insights 
of the life-cycle assessment of the material in various environments. A broad range of different 
characterization techniques have been used to study the physicochemical properties of NMs in 
detail. However, a universal technique capable of assessing all the characteristics of the material 
has not yet been developed; in fact, it has become apparent that every technique has its own 
advantages and shortcomings in terms of NM characterization.  
 
A reference material free reliable quantification sp-ICP-MS method for low concentrated NM 
was successfully developed within the scope of this work. Through the established setup, a 
combination of different mathematical approaches for the calculation of material characteristics 
became feasible. This not only increases the precision of the characterization but also contributes 
to the validation of the ICP-MS technology.  
 
One of the major challenges in the characterization of NMs is their ability to interact with the 
environment and thereby undergo alterations. Whether it is the formation of a protein corona, a 
changed agglomeration behavior or even the dissolution of the material - all these processes 
present a challenge for current analytical techniques, as they are mostly unable to map these 
processes in real time. For the future, the focus of method development should be on the 
establishment and further development of techniques that are able to investigate particles in their 
respective sample matrix and thus describe their respective state exactly at any time. The 
development of a size-standard independent particle characterization has laid the foundation to 
get closer to this goal. Furthermore, the application of a matrix matched calibration approach in 
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combination with a daily response factor contributes towards a reliable und accurate detection of 
NMs in complex matrices.    
 
The factors influencing uptake and subsequent translocation into secondary organs of NMs are 
not yet fully understood. The in vivo investigation of aluminum-containing NMs has given us 
insights into these processes. Our results have shown that despite similar compositions, the 
biokinetics of NMs can differ greatly. In fact, the agglomeration behavior and shape may also 
play a decisive role in these processes. Consequently, extrapolation of the particle translocation 
of NMs is not entirely feasible without clarification of the underlying mechanistic principles. 
Only when these points have been clarified, risk assessment approaches such as grouping can be 
successfully applied to all NMs. 
 
Furthermore, low dose study design challenges conventional analytical methods. We therefore 
implemented a matrix matched calibration process which in combination with a daily response 
factor led to the sensitive and reliable detection of aluminum in matrix-rich samples. Our results 
convincingly show that the application of such a procedure for matrix-rich samples enhances the 
sensitivity of ICP-MS based system and is therefore recommended for such samples.  
 
Cell-based systems can provide important mechanistic insights into the uptake and distribution of 
NMs. We could show that the exposure of aluminum-containing NMs in combination with 
bioactive substances leads to changes in lipid composition and the activation of signaling 
pathways. The combination of Al2O3 and vitamin D3 led to a strong reduction of intracellular 
particle uptake, whereas vitamin D3 and Al0 exposure resulted in an increased uptake of NMs. 
While we could demonstrate that the uptake was caused by a shift in the PC to PE ratio and the 
associated leaky membrane phenomenon the question remains: Which physico-chemical 
difference of the two aluminum containing NM explains this contrasting behavior? By applying 
more sophisticated cell culture systems such as organ-on-a-chip platforms, these questions can 
hopefully be answered for the future and thus contribute to a safer application of NMs. 
 
The work presented here has not only contributed to the advancement in the characterization of 
NMs, but also provided insights into the interaction of NMs with biological systems, both in vivo 
and in vitro. Further studies may adopt and refine these concepts and thus improve the safety of 
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NM applications. However, there is still a lot of basic research to be done before the toxicity of a 
NM can be deduced from its physical and chemical properties only. Nevertheless, considering the 
various opportunities, nanotechnology offers to improve the quality of life. Further efforts should 
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